Feedback / Questions
UshStat (SAR421869) - Oxford Biomedica, Sanofi
Oxford Biomedica: Jefferies Healthcare Conference
(Oxford Biomedica)
-
Jan 1, 2016 -
Anticipated end of P1/2 trial (NCT01505062) in Usher syndrome type 1B in 2017/2018
Anticipated trial completion date
•
Ophthalmology
http://www.oxfordbiomedica.co.uk/uploads/corporate-presentation/oxb-jefferiesconf-nov2015.pdf
Jan 1, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.